Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,289 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
8-K File 001-33038

CURRENT REPORT

Filing date
26 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
19 Jun 2012
Reporting date
19 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
04 Jun 2012
Reporting date
02 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2012
Reporting date
31 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2012
Reporting date
31 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 May 2012
Reporting date
08 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 May 2012
Reporting date
08 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
10 May 2012
Reporting date
08 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
03 May 2012
Reporting date
03 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33038

DEF 14A filing

Filing date
30 Apr 2012
Reporting date
20 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
03 Apr 2012
Reporting date
30 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
03 Apr 2012
Reporting date
03 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
02 Apr 2012
Reporting date
02 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
02 Apr 2012
Reporting date
02 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
29 Feb 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Feb 2012
Reporting date
22 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79364

SCHEDULE 13G AMENDMENT NO. 2

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79364

SC 13G/A filing

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
14 Feb 2012
Reporting date
13 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79364

ZIOPHARM 13G/A

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79364

AMENDMENT NO. 2

Filing date
08 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-162160

424B3

Filing date
03 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .